Blog
Delving Into Glycogen Storage Diseases
BlogIn this interview, Gaia Fancellu, of Iceni Diagnostics, talks about her work in more detail, discusses the challenges of studying GSDs, and highlights the advantages of using a “Systems Medicine” approach to do so.
Read More
Reducing Errors in Whole Genome Sequencing: It Starts with Library Prep
BlogThe highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.
Read More
Detecting the Presence of Cancer in Patients’ Breath
BlogThermo Fisher Scientific and Owlstone Medical have recently entered a collaboration, with the aim of advancing breath diagnostics for the early diagnosis of cancer and other diseases. Dr. Max Allsworth, Chief Science Officer, Owlstone Medical, and Dominic Roberts, Product Marketing Manager, Orbitrap GC-MS, Thermo Fisher Scientific tell us more about the collaboration and the advantages that breath biopsies can bring to disease detection.
Read More
Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?
BlogTechnology Networks recently spoke with Paul Brennan, President and CEO at NervGen Pharma, to gain his insights on why previous attempts to treat Alzheimer's disease have failed, how the novel technology platform NVG-291 works and what promise it holds for AD.
Read More
Motion Capture Trends in Biomechanical Science
BlogIn this article, we discuss current examples of how motion capture technology can be applied across the life sciences industry.
Read More
Ensuring Reliable Material Identification in Pharmaceutical Manufacturing
BlogVariability in the quality of raw materials can not only impact production yields, but can also affect the quality, efficacy and safety of the final pharmaceutical product. In this interview, we spoke with Ana Fiadeiro, senior marketing manager, pharmaceutical vertical leader at Thermo Fisher Scientific, to learn about how the capabilities of two handheld products, the TruScan RM analyzer and the microPHAZIR RX analyzer, ensure reliable material identity verification.
Read More
Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
BlogMany clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?
Read More
Harnessing the Power of Robotics To Transform Drug Discovery
BlogMartin and Tom discuss the evolution of drug discovery, the challenges faced by those working in the field, and share how AI, machine learning and robotics are impacting the discovery and clinical success of drugs.
Read More
Simplifying Next-generation Sequencing in the Clinic
BlogWe recently spoke to Luca Quagliata, Ph.D., Global Head of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific, to discuss some of the barriers preventing full adoption of NGS-based genomic testing in hospitals, and learn more about a solution that can help to address these.
Read More
An Online Educational Resource for Cell Scientists
BlogIntroduced back in March 2019, Cell MentorTM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.
Read More
